Our results revealed that the TAZ/NRF2 positive feedback loop inhibited ferroptosis in bladder cancers by regulating GPX4, offering a novel therapeutic potential for patients with BLCA. The gene discussed is NFE2L2; the disease is urinary bladder cancer.